This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Emisphere Technologies, Inc., Eli Lilly and Company. Active years: 2001-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2013
Title: John Mcneill McGill, III: Innovator in Peptide Delivery Systems
Introduction
John Mcneill McGill, III is a notable inventor based in Greenwood, IN (US). He has made significant contributions to the field of peptide delivery systems, holding a total of 5 patents. His work focuses on the oral delivery of glucagon-like peptide-1 compounds and melanocortin-4 receptor agonist peptides.
Latest Patents
Among his latest patents are innovative compounds, methods, and formulations designed for the oral delivery of glucagon-like peptide-1 compounds or melanocortin-4 receptor agonist peptides. These patents aim to enhance the effectiveness of peptide delivery, making it more accessible and efficient for therapeutic applications.
Career Highlights
Throughout his career, John has worked with prominent companies such as Emisphere Technologies, Inc. and Eli Lilly and Company. His experience in these organizations has allowed him to develop and refine his expertise in peptide delivery systems.
Collaborations
John has collaborated with notable professionals in his field, including Robert Jason Herr and Louis Nickolaus Jungheim. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
John Mcneill McGill, III is a distinguished inventor whose work in peptide delivery systems has the potential to transform therapeutic approaches. His contributions continue to impact the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile